ArticleEuropean journal of cancer (Oxford, England : 1990)2018

The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO.

S Di Cosimo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.